Medical Professionals :: Treatment :: The Visica 2™ Treatment System
-
Innovative, Simple and Highly Effective
The Visica 2™ Treatment System is a premier product for the management and treatment of fibroadenomas. The Visica 2 ICE Probes deliver therapeutic freezing temperatures to targeted tissue to ablate or localize tissue. It is a minimally invasive procedure replacing the more costly surgical procedure for treatment of fibroadenomas (benign breast tumors) and offering a non-surgical in-office approach for your patients. The entire procedure can be performed in-office in about 30 minutes, using local anesthesia.
Visica 2 provides a treatment for fibroadenomas that is minimally invasive with quick recovery, providing complete destruction of the tumor.
The Visica 2 procedure is well-tolerated by patients with excellent cosmetic results. The system delivers complete fibroadenoma destruction with an excellent safety profile; in over 2,000 procedures, not a single regrowth has been reported. Ultrasound-guidance and an easily visible probe and ice ball provide clear imaging throughout the procedure.Visica Specs
Visica Data Sheet.pdf
Visica_2_Brochure.pdf
I’m extremely happy. The scars are
really tiny, like you wouldn’t notice
them at all.If they say you have to have
surgery - ask about cryoablation -
just make sure to ask about it.
- Visica Patient Outcomes Data
The Visica Cryoablation Treatment System offers a highly effective treatment option for fibroadenomas with complete ablation and no reported regrowth in over 2,000 cases. The procedure has very few complications, all are mild and transient. It results in excellent cosmesis, excellent satisfaction rates and virtually no recovery time.
Patient Profile:
- Fibroadenomas ≤ 4 cm diameter
- Patients desiring a minimally invasive and permanent solution
- Patients concerned with cosmetic outcomes
- Patients fully aware of the healing and resorbtion process
Site of Care:
- Physician's office
- Local anesthesia only
- 10-30 minute procedure time
Results:
- No reports of re-growth with more than 2,000 fibroadenomas treated
- 69% of fibroadenomas ≤ 2 cm are non-palpable within 6 months
- 84% of cryoablated fibroadenomas are non-palpable or softer/less prominent at 12 months
- 97% and 100% patient and physician satisfaction at 2.6 years
- Long term (4 year) data is available
- For additional patient outcome data please contact Sanarus